MCAM and syringocystadenoma papilliferum: Contrary to the majority of research undertaken, we have seen that our isolated SCAP populations have lower percentages of CD146 in contrast to STRO-1 (Table 1; Sonoyama et al., 2006; Bakopoulou et al., 2013; Yuan et al., 2014; Zhang et al., 2014).